The National Institutes of Health awarded the grants, which will fund research on autoimmune diseases and human exposure to anthrax.
Alzheimer’s affects 5.8 million Americans, and one in three senior citizens dies with the disease or other forms of dementia.
OMRF scientist Patrick Gaffney has received a five-year, $3.1 million grant to investigate the underlying mechanisms that lead to lupus onset.
The discovery could lead to new therapeutic approaches to a wide range of illnesses, including asthma, inflammatory bowel disease and psoriasis.
New research from OMRF is taking physicians closer to personalized treatment solutions for patients suffering from lupus.
Scientists at OMRF have made new findings that could pave the way for the first drug to treat aortic stenosis.